Stay updated on Pembrolizumab & Cetuximab in HNSCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Cetuximab in HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Cetuximab in HNSCC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page's revision tag has been updated from v3.6.5 to v3.6.6, indicating a minor behind-the-scenes update. There are no visible changes to the study details or information presented to users.
    Difference
    0.0%
    Check dated 2026-08-30T22:22:40.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The study page now displays Revision: v3.6.5, replacing the previous v3.6.4. This indicates a minor update to the page content or formatting.
    Difference
    0.0%
    Check dated 2026-08-09T08:46:28.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4, indicating a minor update to the page template or backend. The change does not modify study details, eligibility criteria, endpoints, or results.
    Difference
    0.0%
    Check dated 2026-07-25T16:51:53.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page's revision tag now shows v3.6.3, replacing v3.6.2. This indicates a minor update to the page’s revision metadata rather than a substantive change to the study content.
    Difference
    0.0%
    Check dated 2026-07-04T13:33:36.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    A new revision label v3.6.2 was added to the revision history, and the older label v3.6.0 was removed.
    Difference
    0.0%
    Check dated 2026-06-27T05:58:21.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Added new sections and guidance (No longer looking for participants; How to Read a Study Record; Common Questions; How to Join a Study) and a page revision label (Revision: v3.6.0). Removed the older 'Intervention / Treatment' header and the previous Revision: v3.5.5.
    Difference
    0.4%
    Check dated 2026-06-12T23:54:25.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Cetuximab in HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Cetuximab in HNSCC Clinical Trial page.